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Fish scales are mineralized structures that play important roles in
protection and mineral homeostasis. This tissue expresses multiple
estrogen receptor subtypes and can be targeted by estrogens or
estrogenic endocrine-disrupting compounds, but their effects are
poorly explored. The transcriptome data here presented support
the ﬁndings reported in the research article “Genistein and
estradiol have common and speciﬁc impacts on the sea bass
(Dicentrarchus labrax) skin-scale barrier” [1]. Juvenile sea bass
were exposed to estradiol and the phytoestrogen genistein for 1
and 5 days, by intraperitoneal injections, and the effects on scale
transcript expression were analysed by RNA-seq using an Illumina
Hi-seq 1500. The raw reads of the 30 libraries produced have been
deposited in the NCBI-SRA database with the project accession
number SRP102504. Mapping of RNA-seq reads against the sea
bass reference genome using the Cufﬂinks/TopHat package iden-
tiﬁed 371 genes that had signiﬁcant (FDR<0.05) differential
expression with the estradiol or genistein treatments in relation to
the control scales at each exposure time, 254 of which presented
more than a 2-fold change in expression. The identity of thej.jsbmb.2019.105448.
dpower@ualg.pt (D.M. Power).
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Table 1 presents the detailed RNA-seq sequence statistics for each of the thirty replicate libraries
that were constructed from sea bass scale RNA, grouped according to treatment: ﬁsh exposed to
estradiol, E2 (E1d and E5d libraries, corresponding to 1 or 5 days of exposure respectively); ﬁsh
exposed to genistein, Gen (Gen1d and Gen5d) and control ﬁsh (C1d and C5d). The transcriptome data
released at the NCBI SRA database (Project SRP102504) contains the raw data ﬁles of the 30 RNA-seq
libraries that were produced from the scales of E2 or Gen-exposed sea bass for each of the six
experimental conditions: C1d (experiment with accession SRX2673957, n ¼ 6 replicate libraries), E1d
(SRX2673962, n¼ 5 libraries), Gen1d (SRX2674307, n¼ 5 libraries), C5d (SRX2674405, n¼ 5 libraries),
E5d (SRX2674467, n ¼ 5 libraries) and Gen5d (SRX2675383, n ¼ 4 libraries).
A total of 749 differentially expressed (DE) genes were identiﬁed. DE genes in the scale tran-
scriptomes of E2-treated or Gen-treated sea bass were identiﬁed by comparison with the corre-
sponding controls at each sampling time and genes changing expression in the control groups when
comparing 1 day vs 5 days of exposure. The expression levels, fold changes and identities of the 332 DE
genes in sea bass scales, that had more than a two-fold change in expression (“DE 2 FC”), are listed in
Supplementary Table 1. A short version of this table (containing only the ﬁrst 20 genes) is displayed in
Table 2. Supplementary Table 2 contains the remaining 417 DE genes (FDR < 0.05 and < 2-fold changes)
and an abbreviated version is presented in Table 3. Table 4 presents the detailed results from the
annotation of the total list of 749 DE genes (that were used for global enrichment analyses), as well asTable 1
Detailed RNA-seq statistics for each library, grouped by treatment. Individual libraries (n ¼ 4e6 from individual ﬁsh) were
prepared from RNA extracted from scales of ﬁsh sampled 1 day after treatment with the vehicle (C1d), estradiol (E1d) or gen-
istein (Gen1d) and scales sampled ﬁve days after each treatment (C5d, E5d and Gen5d, respectively). The number of raw and
ﬁltered reads (in millions), percentage of mapped reads (for each individual library or on average) and the total numbers of reads
produced in the study are presented.
Treatment Lib name Raw reads (millions) Filtered reads (millions) Mapped reads (%)
C1d C1d_1 36.2 33.0 89.3%
C1d_2 32.6 32.6 84.2%
C1d_3 35.7 35.7 85.6%
C1d_4 32.0 32.0 85.1%
C1d_5 32.1 32.1 86.4%
C1d_6 36.1 36.1 86.2%
E1d E1d_1 31.5 31.5 87.2%
E1d_2 37.6 37.6 84.6%
E1d_3 37.6 37.6 84.8%
E1d_4 39.2 39.2 84.1%
E1d_5 31.6 28.3 83.1%
Gen1d Gen1d_1 41.6 41.6 84.0%
Gen1d_2 38.5 35.1 85.4%
Gen1d_3 44.4 44.4 86.1%
Gen1d_4 30.4 30.4 83.7%
Gen1d_5 39.2 38.0 84.5%
C5d C5d_1 40.9 40.9 84.6%
C5d_2 30.7 30.7 87.3%
C5d_3 32.1 32.1 86.6%
C5d_4 29.3 29.3 88.3%
C5d_5 45.8 45.8 85.6%
E5d E5d_1 35.4 35.4 85.6%
E5d_2 36.1 36.1 85.9%
E5d_3 38.8 26.2 87.0%
E5d_4 51.0 49.0 88.9%
E5d_5 44.0 40.8 91.4%
Gen5d Gen5d_1 44.0 44.0 84.5%
Gen5d_2 40.9 40.9 86.1%
Gen5d_3 42.0 42.0 85.9%
Gen5d_4 44.3 44.3 85.7%
Average 37.7 36.8
Total 1131.7 1102.8
Table 2
Selected list (ﬁrst 20 genes) of the genes differentially expressed with a 2-fold difference in sea bass scales from treated versus control animals. The complete list with the expression and
annotation details for the 332 genes with signiﬁcant differential expression (FDR < 0.05 and FC  2) in each comparison can be consulted in Supplementary Table 1. Normalized expression
levels in each experimental group are presented in fragments per kilobase of exon model per million reads mapped (fpkm) and signiﬁcant differential expression for each comparison is
presented in Log2 fold change (FC). The ﬁnal annotation reached using the preference order strategy (Fig. 1 and Table 4) and revised by manual curation is presented, with the accession
numbers from Swiss-Prot, Genbank or from the sea bass genome.
Gene ID Relative expression levels (fpkm) Log2FC of E2
or Gen effects
vs control
at 1d
Log2FC of E2
or Gen effects
vs control
at 5d
Log2FC of
C5d vs C1d
Final gene annotation
Cufﬂinks# C1d E1d Gen1d C5d E5d Gen5d up in
E2
Down
in E2
Up in
Gen
Down
in Gen
E2
up
E2
down
Gen
up
Gen
down
C5d
up
C5d
down
Accession Hit
description
Symbol
XLOC_019555 5.4 14.8 37.7 33.7 5.3 34.0 1.4 e 2.8 e e 2.7 e e 2.6 e O75443 Alpha-tectorin TECTA
XLOC_019129 34.2 225.7 761.3 1735.6 22.0 1398.8 2.7 e 4.5 e e 6.3 e e 5.7 e DLAgn_00248120 Mhc class ii antigen beta chain HLADPB1
XLOC_020058 0.5 3.8 4.0 3.1 6.2 6.0 2.9 e 2.9 e e e e e 2.6 e Q5W7F1 Neutral ceramidase or N-
acylsphingosine amidohydrolase 2
ASAH2
XLOC_019225 25.2 63.2 50.8 25.0 17.3 22.9 1.3 e 1.0 e e e e e e e Q02817 Mucin-2 MUC2
XLOC_019447 10.8 22.6 22.4 12.0 13.6 11.7 1.1 e 1.0 e e e e e e e XP_019109670.1 Integumentary mucin C.1-like MUCC1
XLOC_019084 20.6 47.4 38.1 15.9 14.5 40.0 1.2 e e e e e 1.3 e e e G8HTB6 ZP domain-containing protein /
CUB and zona pellucida like
domains 1
CUZD1
XLOC_019425 437.4 1926.9 1162.0 1718.5 2043.4 2161.0 2.1 e e e e e e e e e P28064 Proteasome subunit beta type-8 PSMB8
XLOC_021846 92.1 215.6 136.4 206.0 144.3 113.2 1.2 e e e e e e e 1.2 e e No hit found e
XLOC_020866 5.0 19.1 5.9 0.6 0.4 1.1 1.9 e e e e e e e e e DLAgn_00214300 Protein fam111a-like FAM111A
XLOC_009298 49.5 135.9 60.4 73.6 55.8 70.0 1.5 e e e e e e e e e DLAgn_00110020 Uncharacterized protein
loc101483146
hyp_loc101483146
XLOC_020865 260.9 1274.3 269.3 12.9 5.6 19.7 2.0 e e e e e e e e e DLAgn_00214300 Protein fam111a-like FAM111A
XLOC_018302 1.6 3.9 2.2 1.6 3.5 1.5 1.3 e e e e e e e e e XP_006805317.1 Uncharacterized protein
LOC102781223
hyp_LOC102781223
XLOC_001638 3.9 4.2 9.2 3.2 6.8 7.9 e e 1.2 e 1.1 e 1.3 e e e P35448 Thrombospondin-1 THBS1
XLOC_009985 1.1 0.6 2.8 0.6 1.9 2.9 e e 1.4 e e e 2.2 e e e P43300 Early growth response protein 3 EGR3
XLOC_009459 2.8 2.5 5.8 2.4 4.4 6.1 e e 1.0 e e e 1.4 e e e Q9ET55 Nocturnin CCRN4L
XLOC_015202 6.1 6.1 19.3 3.5 5.0 8.4 e e 1.7 e e e 1.3 e e e Q16690 Dual speciﬁcity protein
phosphatase 5
DUSP5
XLOC_009646 8.0 5.6 19.0 3.0 7.6 13.2 e e 1.2 e e e 2.2 e e 1.4 Q20A00 DNA damage-inducible transcript
4-like protein
DDIT4L
XLOC_018946 261.3 451.9 567.7 482.9 396.7 190.1 e e 1.1 e e e e 1.3 e e DLAgn_00241010 Complement c1q-like protein 4
precursor
C1QL4
XLOC_011902 6.6 8.2 13.4 20.8 25.4 9.1 e e 1.0 e e e e 1.2 1.7 e XP_005946242.1 RNA-directed DNA polymerase
from mobile element jockey-like
pred_pol413
XLOC_002574 0.8 1.4 2.0 0.8 0.9 1.0 e e 1.3 e e e e e e e Q61391 Neprilysin / membrane metallo-
endopeptidase
MME
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Table 3
Selected list (ﬁrst 20 genes) of the genes differentially expressed at FDR < 0.05 and at < 2-fold change difference, in sea bass scales from treated versus control animals. The complete list with
the expression and annotation for the 417 genes with differential expression under these limits (FDR < 0.05 and FC < 2) can be consulted in Supplementary Table 2. Normalized expression
levels in each experimental group are presented in fragments per kilobase of exon model per million reads mapped (fpkm) and signiﬁcant differential expression for each comparison is
presented in Log2 fold change (FC). The ﬁnal annotation reached using the preference order strategy (Fig. 1 and Table 4) is presented, with the accession numbers from Swiss-Prot, Genbank
or from the sea bass genome.
Gene ID Relative expression levels (fpkm) Log2FC of E2
or Gen effects
vs control
at 1d
Log2FC of E2
or Gen effects
vs control
at 5d
Log2FC of
C5d vs
C1d
Final gene annotation
Cufﬂinks# C1d E1d Gen1d C5d E5d Gen5d E2
up
E2
down
Gen
up
Gen
down
E2
up
E2
down
Gen
up
Gen
down
C5d
up
C5d
down
Hit
description
Symbol
XLOC_017886 20.5 32.3 35.2 21.7 28.2 26.6 0.7 e 0.8 e e e e e e e spjP51890jLUM_CHICK Lumican OS¼Gallus
gallus
LUM
XLOC_009066 20.1 32.2 23.6 14.9 18.8 16.6 0.7 e e e e e e e e e spjQ6NVM0jH10_XENTR Histone H1.0 H1F0
XLOC_000057 39.9 63.9 54.8 51.8 66.1 52.3 0.7 e e e e e e e e e spjQ04857jCO6A1_MOUSE Collagen alpha-
1(VI) chain
COL6A1
XLOC_014484 17.5 28.2 25.8 20.4 14.9 17.2 0.7 e e e e e e e e e spjQ53RD9jFBLN7_HUMAN Fibulin-7 FBLN7
XLOC_019995 42.4 68.5 41.0 32.9 42.9 22.8 0.7 e e e e e e e e e spjP55918jMFAP4_BOVIN Microﬁbril-
associated glycoprotein 4
MFAP4
XLOC_006221 7.3 11.8 7.0 7.3 10.5 6.6 0.7 e e e e e e e e e spjQ4R6P7jSESN1_MACFA Sestrin-1 SESN1
XLOC_002145 58.5 95.2 82.9 108.5 94.2 73.3 0.7 e e e e e e e 0.9 e spjO95428jPPN_HUMAN Papilin PAPLN
XLOC_022309 58.4 96.0 62.0 45.3 81.2 35.5 0.7 e e e 0.8 e e e e e spjQ9U8W8jTL5A_TACTR Techylectin-5A e
XLOC_003581 10.8 18.6 11.2 12.6 8.8 6.9 0.8 e e e e e e 0.9 e e spjQ802Y8jZB16A_DANRE Zinc ﬁnger and
BTB domain-containing protein 16-A
ZBTB16
XLOC_011142 1033.0 1793.0 979.6 1063.6 1387.2 709.6 0.8 e e e e e e e e e spjQ66S03jLECG_THANI Galactose-speciﬁc
lectin nattectin
LADD
XLOC_013333 40.4 70.4 59.7 50.9 50.7 48.9 0.8 e e e e e e e e e spjQ90611jMMP2_CHICK 72 kDa type IV
collagenase
MMP2
XLOC_020568 323.2 571.3 392.8 275.6 447.7 280.9 0.8 e e e e e e e e e gap junction epsilon-1 e
XLOC_016220 5.0 8.9 6.1 6.5 5.6 5.4 0.8 e e e e e e e e e spjQ568Y7jNOE2_RAT Noelin-2 OLFM2
XLOC_006639 175.0 315.2 258.5 221.0 268.7 245.3 0.8 e e e e e e e e e spjQ01584jLIPO_BUFMA Lipocalin LCN1
XLOC_015159 46.9 88.4 67.0 84.6 64.2 95.1 0.9 e e e e e e e 0.9 e spjP27590jUROM_RAT Uromodulin UMOD
XLOC_019689 26.0 49.4 26.6 17.3 18.0 17.4 0.9 e e e e e e e e e No hit found e
XLOC_014167 3.2 6.1 5.1 3.4 2.6 2.7 1.0 e e e e e e e e e spjQ5E9P5jPAMR1_BOVIN Inactive serine
protease PAMR1 OS¼Bos taur... 413 e-114
PAMR1
XLOC_022211 101.7 197.8 148.2 85.2 76.3 155.6 1.0 e e e e e e e e e No hit found e
XLOC_008732 3.6 6.9 6.7 5.9 4.9 5.3 1.0 e 0.9 e e e e e e e spjQ9BQB4jSOST_HUMAN Sclerostin SOST
XLOC_018728 132.5 258.4 160.0 121.5 235.3 99.0 1.0 e e e 1.0 e e e e e No hit found e
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P.I.S. Pinto et al. / Data in brief 27 (2019) 1045876for the selection of the 332 DE genes with  2-fold change. Fig. 1 summarizes the preference order
strategy used to automatically annotate the 332 selected DE genes usingmultiple databases, whichwas
followed by careful manual curation. More details about the annotation strategy can be found in the
methods below and in the methods and results of the associated JSBMB manuscript [1]. Fig. 2 sum-
marizes the number of genes that were DE in response to the treatments (E2 or Gen) or changed
expression between sampling times, when considering different stringency levels: False Discovery
Rate (FDR) < 0.05 and < or  2-fold change in expression. Fig. 3 presents a heatmap showing the
grouping of the six treatment groups, according to the identiﬁed transcriptome changes in sea bass
scales.
Tables 5 and 6 present the signiﬁcantly enriched GO Biological Processes (GO-BP) and KEGG
pathways, respectively, of all genes that presented signiﬁcant changes in expression in response to the
treatments E2 and/or Gen (analysis “All”); Tables 7 and 8 present the signiﬁcantly enriched GO-BP and
KEGGs when directly comparing the E2-or Gen-responsive genes, irrespective of the sampling time
(analyses “E2” vs “Gen”); Tables 9 and 10 list the signiﬁcantly enriched GO-BP and KEGGs when
comparing responsive gene lists between 1 day and 5 days (analyses “1d” vs “5d”).
2. Experimental design, materials, and methods
2.1. Experimental set-up and sampling
The experimental set-up generating the analysed RNAs has been previously described by Pinto et al.
[1,2]. Immature sea bass (n¼ 10/experimental group) received intraperitoneal injections of 5 mg/kg E2
or 5 mg/kg Gen in coconut oil or injection of coconut oil alone (control groups). Individual scales were
plucked with forceps from the same region of the skin (below the dorsal ﬁn) in each ﬁsh, frozen in
liquid nitrogen and stored at 80 C until total RNA extraction.
2.2. Total RNA extraction
An automatedMaxwell 16 Instrument and the SEV (standard elution volume) total RNA puriﬁcation
kit (Promega, Madison, Wisconsin, USA) were used for the extraction of total RNA from n ¼ 15 scales/
individual sea bass. Scales in lysis buffer were mechanically disrupted with an Ultra TurraxTable 4
Detailed results from the annotation. Annotation results (in number of genes or percentage from total) are shown for the 749
genes differentially expressed with q < 0.05 (columns “DE all”) and for the selection of 332 genes differentially expressed at
q < 0.05 with a minimum 2-fold change (columns “DE  2 FC”).
DE all DE  2 FC
Number % Number %
Annotation to different databases:
Genes with BlastX hit to SwissProt 593 79 229 68
Genes assigned to predicted genes in genome 600 80 275 83
Genes with BlastX hit to GenBank 676 90 283 85
Final annotation using preference order:
Genes annotated via SwissProt 593 79 229 68
Genes annotated via the sea bass genome 92 12 61 19
Genes annotated via GenBank 34 5 24 7
Annotated 719 96 314 95
Non-annotated 30 4 18 5
Total number of DE genes 749 100 332 100
Summary of annotation:
Annotation to known proteins 667 89 280 84
Annotation to predicted proteins 21 3 12 4
Annotation to hypothetical/uncharacterized proteins 20 3 14 4
Mapping to non-annotated genes 11 1 8 2
Fig. 1. Annotation to different databases of the 332 genes found to be  2-fold differentially expressed. Venn diagrams indicate the
number of genes with a signiﬁcant match to the sea bass genome, Swiss-Prot protein database or GeneBank protein database, the
number of genes annotated by more than one database are inside the intersecting areas. The annotation was carried out in order of
preference; 1) matches to Swiss-Prot, 2) matches to the sea bass genome and 3) Genbank matches as indicated by the colour
shading. The areas of each sphere are proportional to the number of genes annotated.
Fig. 2. Proportion of differentially expressed (DE) genes identiﬁed in the present study. A. Venn diagrams representing common
(Com.) and speciﬁc genes differentially expressed in sea bass scales in response to the treatments (17b-estradiol, E2, and/or gen-
istein, Gen, compared to the corresponding controls at each sampling time 1 day and 5 days), compared to the differential expression
in the control groups over time. The number of genes by treatment or time and their respective percentage are shown for two levels
of stringency. “DE genes” above the diagram corresponds to the 749 genes differentially expressed at an FDR <0.05. Below the
diagram the DE genes (332) differentially expressed with a minimum of 2-fold change are considered (“DE  2 FC” and FDR < 0.05).
51% of the “DE genes” changed expression only in control scales over time but these changes were of low magnitude (average fold
change of 1.9-fold between C1d and C5d) and when the analysis stringency was increased to a minimum of 2-fold change, only 24%
of these 332 genes changed expression in the control scales over time. The 254 genes (76%) signiﬁcantly regulated by E2 or Genwere
selected for further analyses. B. Shows the comparison of common/speciﬁc DE genes between E2 and Gen at the two stringency
levels, FDR <0.05 or 2 FC and FDR <0.05 (irrespective of the sampling times). For the number of genes regulated by E2 and/or Gen
at each sampling time see Fig. 2B of the associated paper in JSBMB [1].
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Fig. 3. Heatmap of clustered DE genes identiﬁed in sea bass scales after treatment with E2 or Gen. The tree in the upper panel shows
the hierarchical clustering of the DE genes (one gene/line) identiﬁed in the scales of the six treatment groups [injections with
estradiol (E), genistein (G) or vehicle only (control, C) at 1 or 5 days (1d or 5d)]. The red gradient indicates high abundance, the green
gradient indicates low abundance and black indicates equal abundance for each gene and condition relative to the average. 1 day
after treatment the DE genes of the E2 group clustered more closely to the control than Gen1d. 5 days after treatment both E2-and
Gen-treated scales clearly separated from the control and clustered together, suggesting a similar response at this time point.
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Table 5
Enrichment of GO Biological Processes (GO-BP) using all genes found to be differentially expressed in response to E2 and/or Gen
(analysis “All”). Signiﬁcantly enriched biological processes (FDR < 0.05) were identiﬁed by ID and term description and grouped
into 23 functionally related networks (GO group) obtained by ClueGO analysis. Each group is named after its most signiﬁcant
term (lowest FDR) and highlighted in bold, which was chosen for GOTerm representation in Fig. 3 of the associated MS in JSBMB
[1]. Functionally related groups are sorted by highest enrichment score, calculated as [ -Log2 (group FDR)].
GOID GOTerm Term FDR Group FDR Enrichment
Score
GO group % Associated
Genes
Nr. Genes
GO:0043207 response to external
biotic stimulus
7.2E-10 1.8E-10 32.4 18 8.54 21.00
GO:0051707 response to other
organism
7.2E-10 1.8E-10 32.4 18 8.54 21.00
GO:0009615 response to virus 3.8E-05 1.8E-10 32.4 18 12.96 7.00
GO:0009617 response to bacterium 1.5E-03 1.8E-10 32.4 18 5.20 9.00
GO:0051607 defense response to
virus
2.1E-02 1.8E-10 32.4 18 7.14 3.00
GO:0043207 response to external
biotic stimulus
7.2E-10 5.9E-09 27.3 20 8.54 21.00
GO:0051707 response to other
organism
7.2E-10 5.9E-09 27.3 20 8.54 21.00
GO:0051591 response to cAMP 4.8E-05 5.9E-09 27.3 20 75.00 3.00
GO:0009617 response to bacterium 1.5E-03 5.9E-09 27.3 20 5.20 9.00
GO:0046683 response to
organophosphorus
2.3E-03 5.9E-09 27.3 20 20.00 3.00
GO:0014074 response to purine-
containing compound
2.3E-03 5.9E-09 27.3 20 20.00 3.00
GO:0032496 response to
lipopolysaccharide
2.7E-03 5.9E-09 27.3 20 8.33 5.00
GO:0002237 response to molecule of
bacterial origin
3.1E-03 5.9E-09 27.3 20 7.94 5.00
GO:0034097 response to cytokine 3.5E-03 5.9E-09 27.3 20 4.29 9.00
GO:0006954 inﬂammatory response 8.2E-03 5.9E-09 27.3 20 4.32 7.00
GO:0042493 response to drug 1.2E-02 5.9E-09 27.3 20 9.38 3.00
GO:0009612 response to mechanical
stimulus
2.5E-02 5.9E-09 27.3 20 6.67 3.00
GO:0016126 sterol biosynthetic
process
2.9E-09 3.0E-07 21.7 22 31.03 9.00
GO:0006694 steroid biosynthetic
process
4.0E-09 3.0E-07 21.7 22 19.30 11.00
GO:0016125 sterol metabolic
process
9.6E-09 3.0E-07 21.7 22 20.83 10.00
GO:0008202 steroid metabolic
process
1.0E-08 3.0E-07 21.7 22 14.63 12.00
GO:1901617 organic hydroxy
compound biosynthetic
process
8.7E-07 3.0E-07 21.7 22 15.25 9.00
GO:0008203 cholesterol metabolic
process
2.6E-06 3.0E-07 21.7 22 20.59 7.00
GO:1902652 secondary alcohol
metabolic process
4.3E-06 3.0E-07 21.7 22 18.92 7.00
GO:0006695 cholesterol
biosynthetic process
1.1E-05 3.0E-07 21.7 22 31.25 5.00
GO:1902653 secondary alcohol
biosynthetic process
1.8E-05 3.0E-07 21.7 22 27.78 5.00
GO:1901615 organic hydroxy
compound metabolic
process
4.4E-05 3.0E-07 21.7 22 7.69 10.00
GO:0044283 small molecule
biosynthetic process
8.0E-05 3.0E-07 21.7 22 5.85 12.00
GO:0046165 alcohol biosynthetic
process
1.3E-04 3.0E-07 21.7 22 17.86 5.00
GO:0008610 lipid biosynthetic
process
4.1E-04 3.0E-07 21.7 22 4.86 12.00
(continued on next page)
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Table 5 (continued )
GOID GOTerm Term FDR Group FDR Enrichment
Score
GO group % Associated
Genes
Nr. Genes
GO:0006066 alcohol metabolic
process
4.5E-04 3.0E-07 21.7 22 8.33 7.00
GO:0016053 organic acid
biosynthetic process
1.3E-03 3.0E-07 21.7 22 5.97 8.00
GO:0046394 carboxylic acid
biosynthetic process
1.3E-03 3.0E-07 21.7 22 5.97 8.00
GO:1901607 alpha-amino acid
biosynthetic process
1.4E-03 3.0E-07 21.7 22 10.42 5.00
GO:0008652 cellular amino acid
biosynthetic process
1.6E-03 3.0E-07 21.7 22 9.80 5.00
GO:0031099 regeneration 3.0E-03 3.0E-07 21.7 22 4.94 8.00
GO:0031329 regulation of cellular
catabolic process
3.0E-03 3.0E-07 21.7 22 5.51 7.00
GO:0009894 regulation of catabolic
process
3.5E-03 3.0E-07 21.7 22 5.22 7.00
GO:0006520 cellular amino acid
metabolic process
6.5E-03 3.0E-07 21.7 22 4.15 8.00
GO:0022600 digestive system
process
6.9E-03 3.0E-07 21.7 22 12.00 3.00
GO:1901605 alpha-amino acid
metabolic process
7.2E-03 3.0E-07 21.7 22 5.08 6.00
GO:0007586 digestion 1.2E-02 3.0E-07 21.7 22 9.38 3.00
GO:0072330 monocarboxylic acid
biosynthetic process
1.5E-02 3.0E-07 21.7 22 5.97 4.00
GO:0031331 positive regulation of
cellular catabolic
process
1.7E-02 3.0E-07 21.7 22 5.71 4.00
GO:0009896 positive regulation of
catabolic process
1.9E-02 3.0E-07 21.7 22 5.48 4.00
GO:0097164 ammonium ion
metabolic process
2.9E-02 3.0E-07 21.7 22 6.25 3.00
GO:0015748 organophosphate ester
transport
3.5E-02 3.0E-07 21.7 22 5.77 3.00
GO:0006633 fatty acid biosynthetic
process
3.5E-02 3.0E-07 21.7 22 5.77 3.00
GO:0001878 response to yeast 4.6E-06 8.8E-06 16.8 12 25.00 6.00
GO:0009620 response to fungus 1.2E-05 8.8E-06 16.8 12 20.69 6.00
GO:0031099 regeneration 3.0E-03 2.7E-04 11.9 19 4.94 8.00
GO:0009611 response to wounding 3.3E-03 2.7E-04 11.9 19 4.33 9.00
GO:0042060 wound healing 3.4E-03 2.7E-04 11.9 19 4.68 8.00
GO:0022600 digestive system
process
6.9E-03 2.7E-04 11.9 19 12.00 3.00
GO:0007586 digestion 1.2E-02 2.7E-04 11.9 19 9.38 3.00
GO:0042246 tissue regeneration 4.3E-02 2.7E-04 11.9 19 4.08 4.00
GO:0007599 hemostasis 4.5E-02 2.7E-04 11.9 19 5.08 3.00
GO:0007596 blood coagulation 4.5E-02 2.7E-04 11.9 19 5.08 3.00
GO:0050817 coagulation 4.9E-02 2.7E-04 11.9 19 4.84 3.00
GO:0030162 regulation of
proteolysis
3.4E-03 5.6E-03 7.5 11 4.02 10.00
GO:0045861 negative regulation of
proteolysis
1.7E-02 5.6E-03 7.5 11 4.03 6.00
GO:0006270 DNA replication
initiation
6.9E-03 1.2E-02 6.4 0 12.00 3.00
GO:0048593 camera-type eye
morphogenesis
6.4E-03 1.4E-02 6.2 17 4.64 7.00
GO:0048592 eye morphogenesis 7.3E-03 1.4E-02 6.2 17 4.04 8.00
GO:0042462 eye photoreceptor cell
development
1.9E-02 1.4E-02 6.2 17 7.50 3.00
GO:0031076 embryonic camera-
type eye development
3.1E-02 1.4E-02 6.2 17 6.12 3.00
GO:0001754 4.8E-02 1.4E-02 6.2 17 4.92 3.00
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Table 5 (continued )
GOID GOTerm Term FDR Group FDR Enrichment
Score
GO group % Associated
Genes
Nr. Genes
eye photoreceptor cell
differentiation
GO:0006979 response to oxidative
stress
3.7E-03 1.4E-02 6.2 16 7.25 5.00
GO:1990748 cellular detoxiﬁcation 3.1E-02 1.4E-02 6.2 16 6.12 3.00
GO:0098869 cellular oxidant
detoxiﬁcation
3.1E-02 1.4E-02 6.2 16 6.12 3.00
GO:0098754 detoxiﬁcation 3.5E-02 1.4E-02 6.2 16 5.77 3.00
GO:0031589 cell-substrate
adhesion
9.6E-03 1.5E-02 6.1 10 7.02 4.00
GO:0007160 cell-matrix adhesion 3.2E-02 1.5E-02 6.1 10 6.00 3.00
GO:0006730 one-carbon metabolic
process
1.4E-02 1.8E-02 5.8 4 8.57 3.00
GO:0051241 negative regulation of
multicellular
organismal process
1.3E-02 1.8E-02 5.8 3 4.32 6.00
GO:0009266 response to
temperature stimulus
1.7E-02 2.1E-02 5.6 8 7.89 3.00
GO:0072527 pyrimidine-
containing compound
metabolic process
1.9E-02 2.3E-02 5.4 5 7.50 3.00
GO:1901136 carbohydrate
derivative catabolic
process
3.2E-02 3.9E-02 4.7 6 6.00 3.00
GO:0009410 response to xenobiotic
stimulus
3.5E-02 4.0E-02 4.6 9 5.77 3.00
GO:0001945 lymph vessel
development
3.8E-02 4.2E-02 4.6 2 5.56 3.00
GO:0048864 stem cell development 4.1E-02 4.3E-02 4.5 13 4.17 4.00
GO:0014031 mesenchymal cell
development
4.1E-02 4.3E-02 4.5 13 4.17 4.00
GO:0014032 neural crest cell
development
4.1E-02 4.3E-02 4.5 13 4.17 4.00
GO:0000188 inactivation of MAPK
activity
3.4E-04 4.6E-02 4.4 21 22.22 4.00
GO:0043407 negative regulation of
MAP kinase activity
5.6E-04 4.6E-02 4.4 21 19.05 4.00
GO:0043409 negative regulation of
MAPK cascade
1.4E-03 4.6E-02 4.4 21 14.29 4.00
GO:0043405 regulation of MAP
kinase activity
2.0E-03 4.6E-02 4.4 21 7.32 6.00
GO:0071901 negative regulation of
protein serine/
threonine kinase
activity
2.1E-03 4.6E-02 4.4 21 12.50 4.00
GO:0033673 negative regulation of
kinase activity
2.7E-03 4.6E-02 4.4 21 6.67 6.00
GO:0006469 negative regulation of
protein kinase activity
2.7E-03 4.6E-02 4.4 21 6.74 6.00
GO:0051348 negative regulation of
transferase activity
3.3E-03 4.6E-02 4.4 21 6.25 6.00
GO:0001933 negative regulation of
protein
phosphorylation
3.4E-03 4.6E-02 4.4 21 6.12 6.00
GO:0042326 negative regulation of
phosphorylation
3.6E-03 4.6E-02 4.4 21 6.00 6.00
GO:1902532 negative regulation of
intracellular signal
transduction
8.0E-03 4.6E-02 4.4 21 4.96 6.00
(continued on next page)
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Table 5 (continued )
GOID GOTerm Term FDR Group FDR Enrichment
Score
GO group % Associated
Genes
Nr. Genes
GO:0071900 regulation of protein
serine/threonine kinase
activity
8.2E-03 4.6E-02 4.4 21 4.92 6.00
GO:0010563 negative regulation of
phosphorus metabolic
process
9.6E-03 4.6E-02 4.4 21 4.72 6.00
GO:0045936 negative regulation of
phosphate metabolic
process
9.6E-03 4.6E-02 4.4 21 4.72 6.00
GO:0031400 negative regulation of
protein modiﬁcation
process
9.6E-03 4.6E-02 4.4 21 4.72 6.00
GO:0001706 endoderm formation 1.6E-02 4.6E-02 4.4 21 8.11 3.00
GO:0001704 formation of primary
germ layer
1.9E-02 4.6E-02 4.4 21 5.48 4.00
GO:0001666 response to hypoxia 4.4E-02 4.6E-02 4.4 15 5.17 3.00
GO:0070482 response to oxygen
levels
4.6E-02 4.6E-02 4.4 15 5.00 3.00
GO:0036293 response to decreased
oxygen levels
4.6E-02 4.6E-02 4.4 15 5.00 3.00
GO:0009142 nucleoside
triphosphate
biosynthetic process
4.5E-02 4.7E-02 4.4 7 5.08 3.00
GO:0033334 ﬁn morphogenesis 4.5E-02 4.7E-02 4.4 1 5.08 3.00
GO:0042541 hemoglobin
biosynthetic process
1.7E-03 6.2E-02 4.0 14 23.08 3.00
GO:0020027 hemoglobin metabolic
process
2.0E-03 6.2E-02 4.0 14 21.43 3.00
GO:0055076 transition metal ion
homeostasis
4.9E-02 6.2E-02 4.0 14 4.84 3.00
P.I.S. Pinto et al. / Data in brief 27 (2019) 10458712homogenizer (IKA, Staufen, Germany) and a dispersing element specialized for ﬁbrous tissues. The
extracted total RNAwas concentrated by precipitationwith 2 vol (V) of 100% ethanol and 1/10 V of 3 M
sodium acetate pH 5.2 and resuspended in 20e30 ml of Milli-Q ﬁltered water.
RNA quantity and quality were measured in a NanoDrop 1000 spectrophotometer (Thermo Fisher
Scientiﬁc,Waltham,Massachusetts, USA). Between 3 and 10 mg of RNAwere digestedwith DNase, using
a rigorous treatment regime by carrying out two sequential digestions of 30 min with 2U of TURBOTable 6
Enrichment of KEGG pathways using all genes found to be differentially expressed in response to E2 and/or Gen (analysis “All”).
Signiﬁcantly enriched pathways (FDR < 0.05) were identiﬁed by their KEGG identiﬁer and have been grouped according to 7
functionally related groups obtained by ClueGO analysis. Each group is named after its most signiﬁcant term (lowest FDR), which
is indicated in bold. Functionally related groups are sorted by highest enrichment score, calculated as [- Log2 (group FDR)].
KEGG Identiﬁer KEGG ID FDR Group FDR Enrichment Score Groups % Associated Genes Nr. Genes
Steroid biosynthesis 240.0E-9 210.0E-9 22.2 0 33.33 7.00
ECM-receptor interaction 1.5E-3 1.3E-3 9.6 5 8.64 7.00
Alanine, aspartate and
glutamate metabolism
8.7E-3 3.0E-3 8.4 6 10.00 4.00
Arginine biosynthesis 10.0E-3 3.0E-3 8.4 6 12.00 3.00
DNA replication 9.6E-3 6.3E-3 7.3 2 10.53 4.00
p53 signaling pathway 12.0E-3 11.0E-3 6.5 4 6.76 5.00
Arachidonic acid metabolism 11.0E-3 12.0E-3 6.4 1 7.84 4.00
Proteasome 14.0E-3 14.0E-3 6.2 3 7.14 4.00
Table 7
Enrichment of GO Biological Processes (GO-BP) by the genes differentially expressed in response to E2 or to Gen (analyses “E2” vs “Gen”). Signiﬁcantly enriched biological processes
(FDR < 0.05), identiﬁed by their ID and term description, are grouped into 12 functionally related networks (GO group) obtained by ClueGO analysis. Each group is named after its most
signiﬁcant term (lowest FDR), highlighted in bold, which was chosen for group representation in Fig. 3 of the associated MS in JSBMB [1]. Functionally related groups are sorted by the
highest enrichment score, calculated as [- Log2 (group FDR)]. The classiﬁcation of each term as speciﬁcally enriched in response to the E2 or Gen treatments (or both), obtained by ClueGO
cluster analysis, is also shown. For groups including terms enriched in more than one treatment, the classiﬁcation of the leading term was adopted for the group.
GOID GOTerm Term FDR Group FDR Enrichment
Score
GOGroups % Associated
Genes
Nr.
Genes
Treatment %Genes
Speciﬁc
for E2
%Genes
Speciﬁc
for Gen
GO:0043207 Response to external biotic stimulus 540.0E-12 100.0E-12 33.2 7 8.54 21.00 Speciﬁc for Gen 51.67 73.19
GO:0051707 response to other organism 540.0E-12 100.0E-12 33.2 7 8.54 21.00 Speciﬁc for Gen 51.67 73.19
GO:0009615 response to virus 28.0E-6 100.0E-12 33.2 7 12.96 7.00 Speciﬁc for Gen 50.61 63.26
GO:0009617 response to bacterium 1.1E-3 100.0E-12 33.2 7 5.20 9.00 Speciﬁc for Gen 55.51 74.01
GO:0043207 Response to external biotic stimulus 540.0E-12 8.9E-9 26.7 9 8.54 21.00 Speciﬁc for Gen 51.67 73.19
GO:0051707 response to other organism 540.0E-12 8.9E-9 26.7 9 8.54 21.00 Speciﬁc for Gen 51.67 73.19
GO:0051591 response to cAMP 36.0E-6 8.9E-9 26.7 9 75.00 3.00 Speciﬁc for Gen 45.51 68.26
GO:0009617 response to bacterium 1.1E-3 8.9E-9 26.7 9 5.20 9.00 Speciﬁc for Gen 55.51 74.01
GO:0046683 response to organophosphorus 1.8E-3 8.9E-9 26.7 9 20.00 3.00 Speciﬁc for Gen 45.51 68.26
GO:0014074 response to purine-containing
compound
1.8E-3 8.9E-9 26.7 9 20.00 3.00 Speciﬁc for Gen 45.51 68.26
GO:0032496 response to lipopolysaccharide 2.0E-3 8.9E-9 26.7 9 8.33 5.00 Speciﬁc for Gen 49.63 66.17
GO:0002237 response to molecule of bacterial origin 2.3E-3 8.9E-9 26.7 9 7.94 5.00 Speciﬁc for Gen 49.63 66.17
GO:0042493 response to drug 10.0E-3 8.9E-9 26.7 9 9.38 3.00 Speciﬁc for Gen 45.51 68.26
GO:0009612 response to mechanical stimulus 23.0E-3 8.9E-9 26.7 9 6.67 3.00 Speciﬁc for Gen 45.51 68.26
GO:0016126 Sterol biosynthetic process 2.2E-9 1.3E-6 19.6 11 31.03 9.00 Speciﬁc for Gen 20.36 91.63
GO:0006694 steroid biosynthetic process 3.0E-9 1.3E-6 19.6 11 19.30 11.00 Speciﬁc for Gen 17.00 93.49
GO:0016125 sterol metabolic process 7.3E-9 1.3E-6 19.6 11 20.83 10.00 Speciﬁc for Gen 18.53 92.66
GO:0008202 steroid metabolic process 7.7E-9 1.3E-6 19.6 11 14.63 12.00 Speciﬁc for Gen 15.69 94.16
GO:1901617 organic hydroxy compound
biosynthetic process
660.0E-9 1.3E-6 19.6 11 15.25 9.00 Speciﬁc for Gen 20.36 91.63
GO:0008203 cholesterol metabolic process 2.0E-6 1.3E-6 19.6 11 20.59 7.00 Speciﬁc for Gen 25.30 88.56
GO:1902652 secondary alcohol metabolic process 3.2E-6 1.3E-6 19.6 11 18.92 7.00 Speciﬁc for Gen 25.30 88.56
GO:0006695 cholesterol biosynthetic process 8.7E-6 1.3E-6 19.6 11 31.25 5.00 Speciﬁc for Gen 17.96 89.82
GO:1902653 secondary alcohol biosynthetic process 13.0E-6 1.3E-6 19.6 11 27.78 5.00 Speciﬁc for Gen 17.96 89.82
GO:1901615 organic hydroxy compound metabolic
process
33.0E-6 1.3E-6 19.6 11 7.69 10.00 Speciﬁc for Gen 18.53 92.66
GO:0044283 small molecule biosynthetic process 60.0E-6 1.3E-6 19.6 11 5.85 12.00 Speciﬁc for Gen 29.87 89.62
GO:0046165 alcohol biosynthetic process 100.0E-6 1.3E-6 19.6 11 17.86 5.00 Speciﬁc for Gen 17.96 89.82
GO:0008610 lipid biosynthetic process 310.0E-6 1.3E-6 19.6 11 4.86 12.00 Speciﬁc for Gen 15.69 94.16
GO:0006066 alcohol metabolic process 340.0E-6 1.3E-6 19.6 11 8.33 7.00 Speciﬁc for Gen 25.30 88.56
GO:0016053 organic acid biosynthetic process 1.0E-3 1.3E-6 19.6 11 5.97 8.00 Speciﬁc for Gen 32.52 86.72
GO:0046394 carboxylic acid biosynthetic process 1.0E-3 1.3E-6 19.6 11 5.97 8.00 Speciﬁc for Gen 32.52 86.72
(continued on next page)
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Table 7 (continued )
GOID GOTerm Term FDR Group FDR Enrichment
Score
GOGroups % Associated
Genes
Nr.
Genes
Treatment %Genes
Speciﬁc
for E2
%Genes
Speciﬁc
for Gen
GO:1901607 alpha-amino acid biosynthetic process 1.0E-3 1.3E-6 19.6 11 10.42 5.00 Speciﬁc for Gen 33.08 82.71
GO:0008652 cellular amino acid biosynthetic process 1.2E-3 1.3E-6 19.6 11 9.80 5.00 Speciﬁc for Gen 33.08 82.71
GO:0031099 Regeneration 2.2E-3 1.3E-6 19.6 11 4.94 8.00 Speciﬁc for Gen 32.52 86.72
GO:0006520 cellular amino acid metabolic process 5.6E-3 1.3E-6 19.6 11 4.15 8.00 Speciﬁc for Gen 22.58 90.31
GO:0022600 digestive system process 6.0E-3 1.3E-6 19.6 11 12.00 3.00 Speciﬁc for Gen 26.42 79.25
GO:1901605 alpha-amino acid metabolic process 6.3E-3 1.3E-6 19.6 11 5.08 6.00 Speciﬁc for Gen 28.72 86.17
GO:0007586 Digestion 10.0E-3 1.3E-6 19.6 11 9.38 3.00 Speciﬁc for Gen 26.42 79.25
GO:0072330 monocarboxylic acid biosynthetic
process
14.0E-3 1.3E-6 19.6 11 5.97 4.00 Speciﬁc for Gen 38.69 77.37
GO:0031331 positive regulation of cellular catabolic
process
15.0E-3 1.3E-6 19.6 11 5.71 4.00 Both
treatments
58.03 58.03
GO:0009896 positive regulation of catabolic process 17.0E-3 1.3E-6 19.6 11 5.48 4.00 Both
treatments
58.03 58.03
GO:0097164 ammonium ion metabolic process 27.0E-3 1.3E-6 19.6 11 6.25 3.00 Speciﬁc for Gen 26.42 79.25
GO:0015748 organophosphate ester transport 33.0E-3 1.3E-6 19.6 11 5.77 3.00 Speciﬁc for Gen 26.42 79.25
GO:0006633 fatty acid biosynthetic process 33.0E-3 1.3E-6 19.6 11 5.77 3.00 Speciﬁc for Gen 26.42 79.25
GO:0001878 Response to yeast 3.4E-6 4.8E-6 17.7 4 25.00 6.00 Speciﬁc for Gen 43.08 71.80
GO:0009620 response to fungus 9.5E-6 4.8E-6 17.7 4 20.69 6.00 Speciﬁc for Gen 43.08 71.80
GO:0031099 Regeneration 2.2E-3 350.0E-6 11.5 8 4.94 8.00 Speciﬁc for Gen 32.52 86.72
GO:0042060 wound healing 2.8E-3 350.0E-6 11.5 8 4.68 8.00 Speciﬁc for Gen 52.30 73.22
GO:0022600 digestive system process 6.0E-3 350.0E-6 11.5 8 12.00 3.00 Speciﬁc for Gen 26.42 79.25
GO:0007586 Digestion 10.0E-3 350.0E-6 11.5 8 9.38 3.00 Speciﬁc for Gen 26.42 79.25
GO:0042246 tissue regeneration 41.0E-3 350.0E-6 11.5 8 4.08 4.00 Speciﬁc for Gen 38.69 77.37
GO:0007599 Hemostasis 43.0E-3 350.0E-6 11.5 8 5.08 3.00 Speciﬁc for E2 68.26 45.51
GO:0007596 blood coagulation 43.0E-3 350.0E-6 11.5 8 5.08 3.00 Speciﬁc for E2 68.26 45.51
GO:0050817 Coagulation 48.0E-3 350.0E-6 11.5 8 4.84 3.00 Speciﬁc for E2 68.26 45.51
GO:0006979 Response to oxidative stress 3.1E-3 3.9E-3 8.0 1 7.25 5.00 Both
treatments
53.89 53.89
GO:0031589 cell-substrate adhesion 8.6E-3 10.0E-3 6.6 5 7.02 4.00 Speciﬁc for E2 64.60 43.07
GO:0007160 cell-matrix adhesion 30.0E-3 10.0E-3 6.6 5 6.00 3.00 Speciﬁc for E2 79.25 26.42
GO:0006730 One-carbon metabolic process 13.0E-3 13.0E-3 6.3 0 8.57 3.00 Speciﬁc for Gen 0.00 100.00
GO:0051241 negative regulation of multicellular
organismal process
12.0E-3 14.0E-3 6.2 3 4.32 6.00 Speciﬁc for Gen 51.88 77.82
GO:0001945 Lymph vessel development 35.0E-3 35.0E-3 4.8 2 5.56 3.00 Speciﬁc for E2 68.26 45.51
GO:0000188 Inactivation of MAPK activity 260.0E-6 39.0E-3 4.7 10 22.22 4.00 Speciﬁc for Gen 53.43 71.24
GO:0043407 negative regulation of MAP kinase
activity
420.0E-6 39.0E-3 4.7 10 19.05 4.00 Speciﬁc for Gen 53.43 71.24
GO:0043409 negative regulation of MAPK cascade 1.1E-3 39.0E-3 4.7 10 14.29 4.00 Speciﬁc for Gen 53.43 71.24
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GO:0043405 regulation of MAP kinase activity 1.5E-3 39.0E-3 4.7 10 7.32 6.00 Both
treatments
64.85 64.85
GO:0071901 negative regulation of protein serine/
threonine kinase activity
1.5E-3 39.0E-3 4.7 10 12.50 4.00 Speciﬁc for Gen 53.43 71.24
GO:0033673 negative regulation of kinase activity 2.1E-3 39.0E-3 4.7 10 6.67 6.00 Both
treatments
64.85 64.85
GO:0006469 negative regulation of protein kinase
activity
2.1E-3 39.0E-3 4.7 10 6.74 6.00 Both
treatments
64.85 64.85
GO:0051348 negative regulation of transferase
activity
2.6E-3 39.0E-3 4.7 10 6.25 6.00 Both
treatments
64.85 64.85
GO:0001933 negative regulation of protein
phosphorylation
2.9E-3 39.0E-3 4.7 10 6.12 6.00 Both
treatments
64.85 64.85
GO:0042326 negative regulation of phosphorylation 3.0E-3 39.0E-3 4.7 10 6.00 6.00 Both
treatments
64.85 64.85
GO:1902532 negative regulation of intracellular
signal transduction
7.0E-3 39.0E-3 4.7 10 4.96 6.00 Both
treatments
64.85 64.85
GO:0071900 regulation of protein serine/threonine
kinase activity
7.1E-3 39.0E-3 4.7 10 4.92 6.00 Both
treatments
64.85 64.85
GO:0001706 endoderm formation 14.0E-3 39.0E-3 4.7 10 8.11 3.00 Speciﬁc for Gen 45.51 68.26
GO:0001704 formation of primary germ layer 17.0E-3 39.0E-3 4.7 10 5.48 4.00 Speciﬁc for Gen 53.43 71.24
GO:0007492 endoderm development 49.0E-3 39.0E-3 4.7 10 4.76 3.00 Speciﬁc for Gen 45.51 68.26
GO:0042541 Hemoglobin biosynthetic process 1.3E-3 62.0E-3 4.0 6 23.08 3.00 Speciﬁc for Gen 26.42 79.25
GO:0020027 hemoglobin metabolic process 1.5E-3 62.0E-3 4.0 6 21.43 3.00 Speciﬁc for Gen 26.42 79.25
GO:0055076 transition metal ion homeostasis 48.0E-3 62.0E-3 4.0 6 4.84 3.00 Speciﬁc for Gen 26.42 79.25
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Table 8
Enrichment of KEGG pathways by the genes differentially expressed in response to E2 or to Gen (Analyses “E2” vs “Gen”).
Signiﬁcantly enriched pathways (FDR < 0.05), identiﬁed by their KEGG identiﬁer, are grouped according to 6 functionally related
groups obtained by ClueGO analysis. Each group is named after its most signiﬁcant term (lowest FDR) and is highlighted in bold.
Functionally related groups are sorted by highest enrichment score, calculated as [- Log2 (group FDR)].
KEGG Identiﬁer KEGG ID
FDR
Group FDR Enrichment
Score
Groups % Associated
Genes
Nr. Genes Treatment %Genes
Speciﬁc
for E2
%Genes
Speciﬁc
for Gen
Steroid
biosynthesis
210.0E-9 180.0E-9 22.4 0 33.33 7.00 Speciﬁc
for Gen
0.00 100.00
ECM-receptor
interaction
1.3E-3 1.1E-3 9.8 4 8.64 7.00 Speciﬁc
for E2
66.84 40.11
Alanine, aspartate
and glutamate
metabolism
7.6E-3 2.6E-3 8.6 5 10.00 4.00 Speciﬁc
for Gen
21.53 86.14
Arginine
biosynthesis
9.5E-3 2.6E-3 8.6 5 12.00 3.00 Speciﬁc
for Gen
0.00 100.00
DNA replication 8.4E-3 5.4E-3 7.5 1 10.53 4.00 Speciﬁc
for Gen
25.00 75.00
p53 signaling
pathway
11.0E-3 9.5E-3 6.7 3 6.76 5.00 Both
treatments
53.89 53.89
Proteasome 14.0E-3 14.0E-3 6.2 2 7.14 4.00 Speciﬁc
for E2
86.14 21.53
P.I.S. Pinto et al. / Data in brief 27 (2019) 10458716DNAse, as recommended in the instructions of the DNA-free kit (Ambion, Thermo Fisher Scientiﬁc,
Waltham, Massachusetts, USA).2.3. RNA-seq library preparation
The prepared DNase treated RNAs were precipitated with 5 vol of 100% ethanol and shipped in
refrigerated conditions to the Shanghai Ocean University Sequencing Service, Shanghai, China.
Their quality was assessed using a Bioanalyser 2100 (Agilent Technologies, Santa Clara, California,
USA), to conﬁrm that all RNAs had an RNA integrity number (RIN) greater than 8. Library prep-
aration was conducted using a TruSeq mRNA library prep kit (Illumina, San Diego, California, USA),
following the suppliers' instructions. For each library, 0.5 mg of each of the 30 individual RNAs
were used (n ¼ 4e6 individual libraries per treatment, see Table 1). Sequencing of paired-end
(100 bp) reads was carried out using an Illumina Hi-Seq 1500, at the Shanghai Ocean Univer-
sity Sequencing Service.2.4. Sequencing and data analysis
Quality control and trimming of the produced readswas carried out with FastQC and Cutadapt [3,4],
using a Phred quality score cut-off of 20.
Good quality (ﬁltered) reads (Table 1) were then mapped and assembled using the sea bass
reference genome assembly from June 2012 (dicLab v1.0c) and the annotation from July 2013 [5,6], by
running TopHat and Cufﬂinks packages with the data and using the default parameters [7,8]. Relative
expression levels were obtained in fpkm (fragments per kilobase of transcript per million fragments
mapped) for each sea bass gene and differential expression between experimental conditions was
evaluated using Cuffdiff.
Differential expression was evaluated using pairwise comparisons between a) the scales of E2-or
Gen-treated ﬁsh compared to control ﬁsh at the same sampling time (E1d vs C1d, Gen1d vs C1d,
E5d vs C5d or Gen5d vs C5d) or b) between the control groups over time (C1d vs C5d). Two different
stringency conditions were used to identify differentially expressed genes: those passing the condition
FDR <0.05 and those satisfying both conditions FDR <0.05 and a  2-fold change in expression be-
tween the two compared groups.
Table 9
Enrichment of GO Biological Processes by the genes differentially expressed after 1 day or 5 days (Analyses “1d” vs “5d”). Signiﬁcantly enriched biological processes (FDR < 0.05), identiﬁed
by their ID and term description, are grouped according to 11 functionally related networks (GO group) obtained by ClueGO analysis. Each group is named after its most signiﬁcant term
(lowest FDR), highlighted in bold, which was chosen for GOTerm representation in Fig. 3 of the associated MS in JSBMB [1]. Functionally related groups are sorted by highest enrichment
score, calculated as [- Log2 (group FDR)]. The classiﬁcation of each term as speciﬁcally enriched in the responses after 1 day or 5 days (or both), obtained by ClueGO cluster analysis, is also
shown. For groups including terms enriched in more than one list the classiﬁcation of the leading term was adopted for the whole group.
GOID GOTerm Term FDR Group FDR Enrichment
Score
GOGroups % Associated
Genes
Nr. Genes Time %Genes
Speciﬁc for 1d
%Genes Speciﬁc
for 5d
GO:0043207 Response to external biotic
stimulus
490.0E-12 100.0E-12 33.2 7 8.54 21.00 Speciﬁc for 5 days 36.49 72.99
GO:0051707 response to other organism 490.0E-12 100.0E-12 33.2 7 8.54 21.00 Speciﬁc for 5 days 36.49 72.99
GO:0009615 response to virus 26.0E-6 100.0E-12 33.2 7 12.96 7.00 Speciﬁc for 5 days 14.29 85.71
GO:0009617 response to bacterium 1.0E-3 100.0E-12 33.2 7 5.20 9.00 Speciﬁc for 5 days 39.30 78.60
GO:0043207 Response to external biotic
stimulus
490.0E-12 8.9E-9 26.7 9 8.54 21.00 Speciﬁc for 5 days 36.49 72.99
GO:0051707 response to other organism 490.0E-12 8.9E-9 26.7 9 8.54 21.00 Speciﬁc for 5 days 36.49 72.99
GO:0051591 response to cAMP 33.0E-6 8.9E-9 26.7 9 75.00 3.00 Speciﬁc for 5 days 45.51 68.26
GO:0009617 response to bacterium 1.0E-3 8.9E-9 26.7 9 5.20 9.00 Speciﬁc for 5 days 39.30 78.60
GO:0046683 response to organophosphorus 1.7E-3 8.9E-9 26.7 9 20.00 3.00 Speciﬁc for 5 days 45.51 68.26
GO:0014074 response to purine-containing
compound
1.7E-3 8.9E-9 26.7 9 20.00 3.00 Speciﬁc for 5 days 45.51 68.26
GO:0032496 response to lipopolysaccharide 1.9E-3 8.9E-9 26.7 9 8.33 5.00 Speciﬁc for 5 days 33.08 82.71
GO:0002237 response to molecule of
bacterial origin
2.2E-3 8.9E-9 26.7 9 7.94 5.00 Speciﬁc for 5 days 33.08 82.71
GO:0042493 response to drug 10.0E-3 8.9E-9 26.7 9 9.38 3.00 Speciﬁc for 5 days 45.51 68.26
GO:0009612 response to mechanical
stimulus
23.0E-3 8.9E-9 26.7 9 6.67 3.00 Speciﬁc for 5 days 45.51 68.26
GO:0016126 Sterol biosynthetic process 2.0E-9 76.0E-9 23.6 11 31.03 9.00 Speciﬁc for 1 day 84.82 21.21
GO:0006694 steroid biosynthetic process 2.8E-9 76.0E-9 23.6 11 19.30 11.00 Speciﬁc for 1 day 78.95 26.32
GO:0016125 sterol metabolic process 6.6E-9 76.0E-9 23.6 11 20.83 10.00 Speciﬁc for 1 day 86.42 19.21
GO:0008202 steroid metabolic process 7.0E-9 76.0E-9 23.6 11 14.63 12.00 Speciﬁc for 1 day 80.73 24.22
GO:1901617 organic hydroxy compound
biosynthetic process
600.0E-9 76.0E-9 23.6 11 15.25 9.00 Speciﬁc for 1 day 84.82 21.21
GO:0008203 cholesterol metabolic process 1.8E-6 76.0E-9 23.6 11 20.59 7.00 Speciﬁc for 1 day 80.21 26.74
GO:1902652 secondary alcohol metabolic
process
2.9E-6 76.0E-9 23.6 11 18.92 7.00 Speciﬁc for 1 day 80.21 26.74
GO:0006695 cholesterol biosynthetic
process
7.9E-6 76.0E-9 23.6 11 31.25 5.00 Speciﬁc for 1 day 89.82 17.96
GO:1902653 secondary alcohol biosynthetic
process
12.0E-6 76.0E-9 23.6 11 27.78 5.00 Speciﬁc for 1 day 89.82 17.96
GO:1901615 organic hydroxy compound
metabolic process
30.0E-6 76.0E-9 23.6 11 7.69 10.00 Speciﬁc for 1 day 86.42 19.21
(continued on next page)
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Table 9 (continued )
GOID GOTerm Term FDR Group FDR Enrichment
Score
GOGroups % Associated
Genes
Nr. Genes Time %Genes
Speciﬁc for 1d
%Genes Speciﬁc
for 5d
GO:0044283 small molecule biosynthetic
process
54.0E-6 76.0E-9 23.6 11 5.85 12.00 Speciﬁc for 1 day 68.82 45.88
GO:0046165 alcohol biosynthetic process 92.0E-6 76.0E-9 23.6 11 17.86 5.00 Speciﬁc for 1 day 89.82 17.96
GO:0006066 alcohol metabolic process 330.0E-6 76.0E-9 23.6 11 8.33 7.00 Speciﬁc for 1 day 80.21 26.74
GO:0016053 organic acid biosynthetic
process
990.0E-6 76.0E-9 23.6 11 5.97 8.00 Speciﬁc for 5 days 54.20 65.04
GO:0046394 carboxylic acid biosynthetic
process
990.0E-6 76.0E-9 23.6 11 5.97 8.00 Speciﬁc for 5 days 54.20 65.04
GO:1901607 alpha-amino acid biosynthetic
process
1.0E-3 76.0E-9 23.6 11 10.42 5.00 Speciﬁc for 5 days 49.63 66.17
GO:0008652 cellular amino acid biosynthetic
process
1.1E-3 76.0E-9 23.6 11 9.80 5.00 Speciﬁc for 5 days 49.63 66.17
GO:0072330 monocarboxylic acid
biosynthetic process
14.0E-3 76.0E-9 23.6 11 5.97 4.00 Both times 58.03 58.03
GO:0031331 positive regulation of cellular
catabolic process
16.0E-3 76.0E-9 23.6 11 5.71 4.00 Speciﬁc for 5 days 43.07 64.60
GO:0009896 positive regulation of catabolic
process
17.0E-3 76.0E-9 23.6 11 5.48 4.00 Speciﬁc for 5 days 43.07 64.60
GO:0097164 ammonium ion metabolic
process
27.0E-3 76.0E-9 23.6 11 6.25 3.00 Speciﬁc for 1 day 79.25 26.42
GO:0001878 Response to yeast 3.1E-6 4.8E-6 17.7 5 25.00 6.00 Both times 50.00 50.00
GO:0009620 response to fungus 8.6E-6 4.8E-6 17.7 5 20.69 6.00 Both times 50.00 50.00
GO:0031099 Regeneration 2.1E-3 150.0E-6 12.7 8 4.94 8.00 Speciﬁc for 1 day 75.88 43.36
GO:0042060 wound healing 2.7E-3 150.0E-6 12.7 8 4.68 8.00 Speciﬁc for 1 day 73.22 52.30
GO:0042246 tissue regeneration 42.0E-3 150.0E-6 12.7 8 4.08 4.00 Speciﬁc for 1 day 77.37 38.69
GO:0007599 hemostasis 44.0E-3 150.0E-6 12.7 8 5.08 3.00 Speciﬁc for 5 days 45.51 68.26
GO:0007596 blood coagulation 44.0E-3 150.0E-6 12.7 8 5.08 3.00 Speciﬁc for 5 days 45.51 68.26
GO:0050817 coagulation 49.0E-3 150.0E-6 12.7 8 4.84 3.00 Speciﬁc for 5 days 45.51 68.26
GO:0006979 Response to oxidative stress 2.9E-3 3.9E-3 8.0 0 7.25 5.00 Speciﬁc for 1 day 60.00 40.00
GO:0031589 Cell-substrate adhesion 8.6E-3 10.0E-3 6.6 3 7.02 4.00 Speciﬁc for 5 days 43.07 64.60
GO:0009266 Response to temperature
stimulus
15.0E-3 19.0E-3 5.7 2 7.89 3.00 Speciﬁc for 1 day 100.00 0.00
GO:0000188 Inactivation of MAPK activity 230.0E-6 29.0E-3 5.1 10 22.22 4.00 Speciﬁc for 5 days 38.69 77.37
GO:0043407 negative regulation of MAP
kinase activity
400.0E-6 29.0E-3 5.1 10 19.05 4.00 Speciﬁc for 5 days 38.69 77.37
GO:0043409 negative regulation of MAPK
cascade
1.0E-3 29.0E-3 5.1 10 14.29 4.00 Speciﬁc for 5 days 38.69 77.37
GO:0043405 regulation of MAP kinase
activity
1.4E-3 29.0E-3 5.1 10 7.32 6.00 Speciﬁc for 5 days 28.72 86.17
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GO:0071901 negative regulation of protein
serine/threonine kinase activity
1.4E-3 29.0E-3 5.1 10 12.50 4.00 Speciﬁc for 5 days 38.69 77.37
GO:0033673 negative regulation of kinase
activity
1.9E-3 29.0E-3 5.1 10 6.67 6.00 Speciﬁc for 5 days 54.36 67.96
GO:0006469 negative regulation of protein
kinase activity
1.9E-3 29.0E-3 5.1 10 6.74 6.00 Speciﬁc for 5 days 54.36 67.96
GO:0051348 negative regulation of
transferase activity
2.5E-3 29.0E-3 5.1 10 6.25 6.00 Speciﬁc for 5 days 54.36 67.96
GO:0001933 negative regulation of protein
phosphorylation
2.7E-3 29.0E-3 5.1 10 6.12 6.00 Speciﬁc for 5 days 54.36 67.96
GO:0042326 negative regulation of
phosphorylation
2.8E-3 29.0E-3 5.1 10 6.00 6.00 Speciﬁc for 5 days 54.36 67.96
GO:1902532 negative regulation of
intracellular signal transduction
7.0E-3 29.0E-3 5.1 10 4.96 6.00 Speciﬁc for 5 days 54.36 67.96
GO:0071900 regulation of protein serine/
threonine kinase activity
7.1E-3 29.0E-3 5.1 10 4.92 6.00 Speciﬁc for 5 days 28.72 86.17
GO:0001706 endoderm formation 15.0E-3 29.0E-3 5.1 10 8.11 3.00 Speciﬁc for 5 days 26.42 79.25
GO:0001704 formation of primary germ
layer
17.0E-3 29.0E-3 5.1 10 5.48 4.00 Speciﬁc for 5 days 21.53 86.14
GO:0001945 Lymph vessel development 37.0E-3 39.0E-3 4.7 4 5.56 3.00 Speciﬁc for 1 day 68.26 45.51
GO:0009142 Nucleoside triphosphate
biosynthetic process
44.0E-3 44.0E-3 4.5 1 5.08 3.00 Speciﬁc for 5 days 0.00 100.00
GO:0042541 Hemoglobin biosynthetic
process
1.2E-3 62.0E-3 4.0 6 23.08 3.00 Speciﬁc for 5 days 26.42 79.25
GO:0020027 hemoglobin metabolic process 1.4E-3 62.0E-3 4.0 6 21.43 3.00 Speciﬁc for 5 days 26.42 79.25
GO:0055076 transition metal ion
homeostasis
49.0E-3 62.0E-3 4.0 6 4.84 3.00 Speciﬁc for 5 days 26.42 79.25
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Table 10
Enrichment of KEGG pathways by the genes differentially expressed after 1 day or 5 days (analyses “1d” vs “5d”). Signiﬁcantly
enriched pathways (FDR < 0.05), identiﬁed by their KEGG identiﬁer, are grouped according to 7 functionally related groups
obtained by ClueGO analysis.
KEGG Identiﬁer KEGG
ID FDR
Group FDR Enrichment
Score
Groups % Associated
Genes
Nr. Genes Time %Genes
Speciﬁc
for 1d
%Genes
Speciﬁc
for 5d
p53 signaling
pathway
11.0E-3 11.0E-3 6.5 5 6.76 5.00 Both times 53.89 53.89
Steroid
biosynthesis
210.0E-9 210.0E-9 22.2 0 33.33 7.00 Speciﬁc for 1d 100.00 0.00
ECM-receptor
interaction
1.3E-3 1.3E-3 9.6 6 8.64 7.00 Speciﬁc for 1d 66.84 40.11
Alanine,
aspartate and
glutamate
metabolism
7.6E-3 7.6E-3 7.0 1 10.00 4.00 Speciﬁc for 1d 64.60 43.07
DNA replication 8.4E-3 8.4E-3 6.9 3 10.53 4.00 Speciﬁc for 5 d 25.00 75.00
Arachidonic
acid
metabolism
12.0E-3 12.0E-3 6.4 2 7.84 4.00 Speciﬁc for 5 d 25.00 75.00
Proteasome 14.0E-3 14.0E-3 6.2 4 7.14 4.00 Speciﬁc for 5 d 21.53 86.14
P.I.S. Pinto et al. / Data in brief 27 (2019) 10458720The common or speciﬁc genes identiﬁed between different lists of E2 or Gen DE genes were rep-
resented by area proportional Venn diagrams generated with BioVenn [9,10], using their Cufﬂinks
XLOC identiﬁers (see Supplementary Table 1). Similarities between global transcriptome changes
identiﬁed for the six experimental conditions (C1d, E1d, Gen1d, C5d, E5d and Gen5d) were evaluated
by hierarchical clustering with Cluster 3.0 [11,12], using median centered expression data after Log2
transformation of normalized gene expression (fpkm) levels. The uncentered correlation option and
complete linkage options were used to cluster group arrays (experimental conditions).2.5. Gene and functional annotations
The 749 genes for which differential expression was detected with FDR <0.05 were subjected to a
multistep automatic gene annotation strategy. Stand-alone Blastx analyses of the corresponding Cuf-
ﬂinks transcripts (individual sequences extracted from the sea bass annotated genes coding sequences,
between the mapping positions) were run against the Swiss-Prot curated protein database [13,14] and
the unreviewed GenBank protein database [15,16], with expect values (E) set at a maximum of 1010.
These Blastx results were then combined and compared with the Cufﬂinks mappings to the annotated
sea bass genome [5,6]. For genome mapping, the annotation of the closest gene was used as long as a
maximum distance of 1000 bp existed between this gene and the mapping position of the Cufﬂinks
transcript.
A hierarchical preference order was deﬁned to assign annotation matches to the differentially
expressed genes, which was Swiss-Prot hits > sea bass genome hits > GenBank hits, as represented in
Fig. 1. Genes were annotated using Swiss-Prot hits for all genes that gave signiﬁcant hits with this
curated database; when no Swiss-Prot hits were found genes were annotated using genome mapping
and genes with no signiﬁcant annotation using the two previous databases were annotated using the
non-curated Genbank protein database.
In addition, 54% of the 332 DE genes with  2-fold change were manually curated to verify the
accuracy of the annotations. For this process, individual Cufﬂinks transcript sequences extracted from
the mapping positions were re-annotated using individual BLAT versus the sea bass genome [5,6],
compared with the sea bass annotations of these and close by genes. Their predicted coding sequences
were blasted against the Swiss-Prot and GenBank protein databases, followed by a careful veriﬁcation
by multisequence alignments carried out with MultAlin [17,18].
Gene ontology (GO) and pathway (KEGG) enrichment analyses were carried out using Cytoscape
v3.5.1 [19] and ClueGO plug-in v2.3.2 [20], with Cluepedia v1.3.2. The zebraﬁsh (Danio rerio)
P.I.S. Pinto et al. / Data in brief 27 (2019) 104587 21orthologues for the 371 genes found to be DE with E2 or Gen treatments at FDR<0.05 were identiﬁed
using stand-alone BlastX (with E value < 1010) against the Ensembl zebraﬁsh protein predictions (GRC
Zebraﬁsh Build 10, INSDC Assembly GCA_000002035.3 from Sep 2014, downloaded in Feb 2017 at
https://www.ensembl.org/ [21]). D. rerio Ensembl protein IDs corresponding to each list of DE genes
(“All” ¼ all genes regulated by E2 and/or Gen; “E2” or “Gen” ¼ genes regulated by each treatment
irrespective of the sampling time and “1d” or “5d” ¼ genes regulated after 1 or 5 days by either E2 or
Gen) were then submitted to the Cytoscape/ClueGO plug-in. This was run using the following settings:
enrichment analysis (right-sided hypergeometric test) using GO Biological Process (GO BP, levels 3e8)
terms for D. rerio updated on 13/05/2017; BenjaminieHochberg false discovery rate (FDR) correction
with only termswith FDR 0.05 and aminimum of three genes/4% being considered signiﬁcant; Initial
group size (for grouping into functionally related networks of enriched terms) set as 1 and group
merging at 50%, with a Kappa-statistics score threshold set at 0.4. The enrichment score for each
functionally related network group was calculated as -Log2 (group FDR). The leading terms for each
group were selected based on their highest enrichment score (lowest term FDR) and were used for
group naming in tables and condensed bar plot representations and for evaluation of treatment speciﬁc
enrichment. Parallel enrichment analyses were carried out for the Kyoto Encyclopaedia of Genes and
Genomes (KEGG) pathways for each DE list, using the same parameters and strategy as described for
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